Life Sciences
Apiam Animal Health Limited (ASX:AHX) is pleased to release its full year results for the 6-months to 31 December 2022 (H1 FY23).
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.
Apiam Animal Health Ltd (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire on the recent acquisitions the company has made in the mixed animal veterinary industry.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of two mixed animal veterinary businesses in strategic NSW regions (the Acquisitions), for total consideration of $11.2 million.
American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease
Apiam Animal Health Limited (ASX:AHX) is pleased to announce that it has completed the settlement of Hunter Equine Centre Pty Ltd (Hunter Equine Centre, HEC), a dedicated equine veterinary business located in the Upper Hunter Valley region of NSW.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of Hunter Equine Centre Pty Ltd (Hunter Equine Centre (HEC), the Acquisition), a dedicated equine veterinary business located in the Upper Hunter Valley region of NSW.
Apiam Animal Health Limited (ASX:AHX) has expanded in Western Australia, via the acquisition of Harradine & Associates announced last week.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of Harradine & Associates, a large veterinary business located in the southwest region of Western Australia.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the appointment of Ms Evonne Collier as a Non-Executive Director to the Company's Board of Directors, with effect from 1 October.
Banking & Finance
- NSX Limited (ASX:NSX) Quarterly Activities Report
- Advisory Board Sharpens Focus for the 2024 Australian Gold Conference
- NSX Limited (ASX:NSX) Non-Renounceable Issue - Close of Offer and Shortfall